Mutated atrx gene linked to brain and pancreatic neuroendocrine tumors is potential biomarker for rare adrenal tumors too

21 enero 2015

For the first time, researchers have found that a mutation in the ATRX gene may serve as a much-needed biomarker for the pheochromocytomas and paragangliomas that become malignant. These rare neuroendocrine tumors are typically benign, but when they go rogue, they become very aggressive.